AVCR — Avricore Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.06m
- CA$3.78m
- CA$4.79m
Annual cashflow statement for Avricore Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.17 | -1.71 | -0.818 | -0.701 | -0.669 |
| Depreciation | |||||
| Non-Cash Items | 0.421 | 0.534 | 0.34 | 0.708 | 1.34 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.471 | -0.078 | -0.143 | 0.233 | -0.112 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.22 | -1.23 | -0.438 | 0.66 | 1 |
| Capital Expenditures | — | -0.14 | -1.2 | -1.05 | -0.205 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -0.01 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.14 | -1.21 | -1.05 | -0.205 |
| Financing Cash Flow Items | -0.045 | -0.099 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.51 | 3.08 | 0.254 | 0.043 | 0.057 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.289 | 1.71 | -1.39 | -0.344 | 0.856 |